Mesa Laboratories Inc (MLAB) Q2 2027 Earnings Call Highlights: Margin Expansion and ...
Mesa Laboratories Inc (MLAB) posted 2.6% organic revenue growth with adjusted EBITDA up 21.1%, while restructuring clinical genomics and resolving a key SDC product line remain top priorities. Related Stocks: MLAB ,